ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 185 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2020. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1,859 | -89.7% | 1,169 | -59.5% | 0.00% | -100.0% |
| Q4 2022 | $17,974 | -18.3% | 2,885 | -12.5% | 0.00% | 0.0% |
| Q3 2022 | $22,000 | +22.2% | 3,298 | +13.9% | 0.00% | 0.0% |
| Q2 2022 | $18,000 | +800.0% | 2,895 | +667.9% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 377 | -57.4% | 0.00% | – |
| Q4 2021 | $4,000 | +300.0% | 884 | +820.8% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 96 | +405.3% | 0.00% | – |
| Q2 2020 | $1,000 | – | 19 | +1800.0% | 0.00% | – |
| Q4 2018 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $22,344,000 | 10.09% |
| Altium Capital Management LP | 2,515,785 | $12,579,000 | 3.47% |
| Deep Track Capital, LP | 5,641,668 | $28,208,000 | 1.99% |
| Paradigm Biocapital Advisors LP | 839,257 | $4,196,000 | 1.20% |
| SABBY MANAGEMENT, LLC | 940,400 | $4,702,000 | 0.68% |
| Monaco Asset Management SAM | 500,000 | $2,500,000 | 0.62% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,000,000 | $25,000,000 | 0.52% |
| CVI Holdings, LLC | 1,460,595 | $7,303,000 | 0.48% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $13,566,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,000,000 | $4,960,000 | 0.33% |